Alan Roemer

Alan S.
Roemer is Chairman at UTILITY therapeutics Ltd. since 2020.
Mr. Roemer is Director at DC Brau Brewing LLC.
Mr. Roemer is Trustee at Helene Fuld College of Nursing since 2014.
Former roles include Chairman at IN8bio, Inc. from 2020 to 2026, Director at Bit Bio Ltd. from 2021 to 2024, Managing Director at Trout Capital LLC from 2009 to 2014, Director at Sompharmaceuticals SA from 2012 to 2016, Managing Director at The Trout Group LLC from 2009 to 2014, Director at Envisagenics, Inc. from 2021 to 2023, Independent Director at NexImmune, Inc. from 2019 to 2024, Principal at Bank of America Corp., Chief Financial Officer & Treasurer at Azelon Pharmaceuticals, Inc. from 2008 to 2009, Vice President-Investor Relations at Pharmasset, Inc. from 1999 to 2008, Consultant at Deloitte Consulting LLP, Consultant at Booz Allen Hamilton International (U.K.) Ltd., Chief Financial & Accounting Officer at Sio Gene Therapies, Inc. in 2015, Chief Financial Officer at Axovant Sciences, Inc. in 2015, and Senior Vice President & Member at Roivant Sciences, Inc. from 2014 to 2019.
Education includes undergraduate studies at Georgetown University, an MBA from Goizueta Business School-Emory, and graduate studies at Rollins School of Public Health.